Ask AI
ProCE Banner Activity

Managing Patients With Myelofibrosis and First-line Treatment Failure

Slideset Download
Download this slideset from a live symposium at ASH 2022 to review current best practices and emerging strategies for treating patients with myelofibrosis who have received previous therapies (including ruxolitinib).

Released: December 09, 2022

Share

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by educational grants from

AbbVie Inc.

CTI BioPharma Corp., a Sobi Company

Faculty Disclosure

Primary Author

Abdulraheem Yacoub, MD

Professor of Medicine
Clinical Director of Ambulatory Hematology Clinics
The Division of Hematologic Malignancies and Cellular Therapeutics (HMCT)
Department of Internal Medicine
The University of Kansas Cancer Center
Kansas City, Kansas